NSI Equity Snapshot
ORCHPHARMA Weekly Equity Report
Orchid Pharma Limited
What the company does
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins; human and veterinary products; and antibiotics, including betalactam, macrolide, fluoroquinolone, and imidazole. The company also exports its products to approximately 40 countries internationally. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai, India. …
What the weekly tape is saying
ORCHPHARMA closed the latest completed week at 917.1 INR. The 4-week return is 28.7% and the 12-week return is 72.2%. Trend Signal is inactive, Market Dynamics is 1.29. Setup signature: Early recovery watch with a 77/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 693.7 INR
- Vs Trend Line
- 32.2%
- Fair Value
- 905.1 INR
- Vs Fair Value
- 1.3%
- 52W High
- 935.0 INR
- 52W Low
- 480.0 INR
- Drawdown
- -1.9%
- Range Position
- 96.1%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 9
- 52W Active Breadth
- 17.3%
- Sector Scope
- IN Healthcare
- Sector Rank
- 20 of 161
- Sector Percentile
- 88.1%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
IN Healthcare
- Tracked Peers
- 100
- 4W Rank
- 7 of 100
- Avg 1W
- 2.2%
- Avg 4W
- 5.7%
- Trend Breadth
- 55.0%
- Positive MD
- 90.0%
IN Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 92
- 4W Rank
- 7 of 92
- Avg 1W
- 2.0%
- Avg 4W
- 7.4%
- Trend Breadth
- 50.0%
- Positive RS
- 65.2%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 1.29
- 4W MD Change
- 183.3%
- Relative Strength
- 35.38
- 4W RS Change
- 413.8%
- Expectation
- Undecided
- Probability
- 49.43%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 965.4K
- 13W Average
- 450.8K
- 52W Average
- 438.4K
- Vs 13W
- 2.1x
- Vs 52W
- 2.2x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 5.2%
- 52W Volatility
- 6.2%
- Upside Weeks
- 26
- Downside Weeks
- 26
- Downside Breadth
- 50.0%
- Avg Gain / Loss
- 5.5% / -4.1%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NSI
- Country
- IN
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- INR
- Market Cap
- 40.2B
Opportunity signals
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
Watch next
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 917.1 INR | 8.6% | 693.7 INR | 905.1 INR | 1.29 | 35.38 | 965.4K | Off |
| 5 Jun 2026 | 844.2 INR | 6.5% | 689.9 INR | 901.9 INR | 1.10 | 26.83 | 592.2K | Off |
| 29 May 2026 | 792.5 INR | 12.2% | 689.8 INR | 899.2 INR | 0.98 | 18.74 | 633.0K | Off |
| 22 May 2026 | 706.5 INR | -0.9% | 687.6 INR | 896.8 INR | 0.72 | 5.68 | 248.2K | Off |
| 15 May 2026 | 712.6 INR | 1.3% | 688.1 INR | 894.9 INR | 0.46 | 6.88 | 463.3K | Off |
| 8 May 2026 | 703.5 INR | 12.4% | 688.5 INR | 893.1 INR | 0.03 | 3.15 | 420.2K | Off |
| 1 May 2026 | 625.8 INR | 10.4% | 689.9 INR | 891.4 INR | -0.43 | -7.76 | 339.3K | Off |
| 24 Apr 2026 | 566.8 INR | -0.4% | 693.8 INR | 889.9 INR | -0.76 | -16.48 | 427.0K | Off |
| 17 Apr 2026 | 569.4 INR | 1.9% | 699.0 INR | 888.8 INR | -0.92 | -18.22 | 220.6K | Off |
| 10 Apr 2026 | 558.7 INR | 6.7% | 706.3 INR | 887.6 INR | -0.98 | -19.24 | 325.5K | Off |
| 3 Apr 2026 | 523.8 INR | 4.3% | 711.4 INR | 886.5 INR | -0.94 | -20.27 | 312.0K | Off |
| 27 Mar 2026 | 502.3 INR | -5.7% | 717.7 INR | 885.6 INR | -0.99 | -24.40 | 434.2K | Off |
| 20 Mar 2026 | 532.5 INR | 4.0% | 725.4 INR | 884.9 INR | -0.91 | -21.44 | 479.2K | Off |
| 13 Mar 2026 | 512.1 INR | 0.7% | 733.4 INR | 883.9 INR | -0.91 | -25.18 | 715.4K | Off |